Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.
Eikon Therapeutics, Inc. (EIKN) had Cash Flow from Investing Activities of -181.34M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
-333.64M |
|
-- |
|
-- |
|
338.94M |
|
-338.94M |
|
14.70M |
|
-324.25M |
|
-324.25M |
|
-324.25M |
|
-324.25M |
|
-324.25M |
|
-324.25M |
|
-338.94M |
|
-314.77M |
|
2.89M |
|
2.89M |
|
-115.29 |
|
-115.29 |
|
| Balance Sheet Financials | |
348.92M |
|
142.90M |
|
245.82M |
|
594.73M |
|
55.01M |
|
-- |
|
1.42B |
|
1.47B |
|
-879.03M |
|
-879.03M |
|
-879.03M |
|
-- |
|
| Cash Flow Statement Financials | |
-188.52M |
|
|
Cash Flow from Investing Activities |
-181.34M |
352.05M |
|
130.88M |
|
113.07M |
|
-17.81M |
|
18.04M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.34 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-235.26M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
36.89% |
|
36.89% |
|
-54.52% |
|
36.89% |
|
-- |
|
-81.29 |
|
-65.14 |
|